EIQ Shares Echo IQ Limited
ASX · ASXLast in our picks 2026-10-19 — not in the current list; analysis below is from that screen
AI cardiac diagnostics could address large unmet needs if clinical validation converts commercially.
Signal breakdown
- ▸Clinical adoption milestones offer asymmetric upside with significant execution risk.
- ▾Below 50-day MA (-56.16%)
- ▾Near 52-week low (14.4% of range)
Is EIQ a buy right now?
Trend: EIQ is trading below the 50-day average (-35.63%), RSI 76 — overbought territory, with a 3-month return of -59.13%.
Valuation & quality: Echo IQ Limited trades on forward P/E -30.6, price-to-book 28.61; fundamentals show net margin 0.0%, return on equity -108.0%.
Analyst consensus: 4 analysts have a mean 12-month price target of A$0.91 (+77.2% vs the last close; range A$0.30 – A$1.55), consensus rating “none”.
Our screen: WATCH (score 0) — AI cardiac diagnostics could address large unmet needs if clinical validation converts commercially.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +43.50% | +5.60% | +43.60% | +17.80% | -16.40% | +6.00% | -57.40% | -15.00% |
Fundamentals
Analyst price target
Technical signals
About Echo IQ Limited
Echo IQ Limited, an artificial intelligence (AI) and medical technology company, engages in the development and application of AI for the cardiac diagnostics sector in Australia.
Sector: Healthcare · Industry: Health Information Services · Australia · Website
Related Artificial Intelligence picks
Browse: all ASX stocks · Artificial Intelligence picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.